2023-11-01 2024-10-31 false No description of principal activity Capium Accounts Production 1.1 12286983 2023-11-01 2024-10-31 12286983 bus:FullAccounts 2023-11-01 2024-10-31 12286983 bus:FRS102 2023-11-01 2024-10-31 12286983 bus:AuditExemptWithAccountantsReport 2023-11-01 2024-10-31 12286983 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2024-10-31 12286983 bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 12286983 2023-11-01 2024-10-31 12286983 2024-10-31 12286983 bus:RegisteredOffice 2023-11-01 2024-10-31 12286983 core:WithinOneYear 2024-10-31 12286983 core:AfterOneYear 2024-10-31 12286983 1 2023-11-01 2024-10-31 12286983 bus:Director1 2023-11-01 2024-10-31 12286983 bus:Director1 2024-10-31 12286983 bus:Director1 2022-11-01 2023-10-31 12286983 2022-11-01 12286983 bus:LeadAgentIfApplicable 2023-11-01 2024-10-31 12286983 2022-11-01 2023-10-31 12286983 2023-10-31 12286983 core:WithinOneYear 2023-10-31 12286983 core:AfterOneYear 2023-10-31 12286983 bus:EntityAccountantsOrAuditors 2022-11-01 2023-10-31 12286983 bus:OrdinaryShareClass1 2023-11-01 2024-10-31 12286983 bus:OrdinaryShareClass1 2024-10-31 12286983 bus:OrdinaryShareClass1 2022-11-01 2023-10-31 12286983 bus:OrdinaryShareClass1 2023-10-31 12286983 core:ComputerEquipment 2023-11-01 2024-10-31 12286983 core:ComputerEquipment 2024-10-31 12286983 core:ComputerEquipment 2023-10-31 12286983 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-10-31 12286983 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-10-31 12286983 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 12286983 core:CostValuation core:Non-currentFinancialInstruments 2023-10-31 12286983 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-10-31 12286983 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-10-31 12286983 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-10-31 12286983 core:Non-currentFinancialInstruments 2024-10-31 12286983 core:Non-currentFinancialInstruments 2023-10-31 12286983 core:ShareCapital 2024-10-31 12286983 core:ShareCapital 2023-10-31 12286983 core:RetainedEarningsAccumulatedLosses 2024-10-31 12286983 core:RetainedEarningsAccumulatedLosses 2023-10-31 12286983 dpl:Item1 2023-11-01 12286983 dpl:Item1 2024-10-31 12286983 dpl:Item1 2022-11-01 12286983 dpl:Item1 2023-10-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12286983
England and Wales

 

 

 

YOUR EYE CARE LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 November 2023

End date: 31 October 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3   390 
  390 
Current assets      
Cash at bank and in hand 16,939    11,347 
Creditors: amount falling due within one year 4 (7,907)   (10,095)
Net current assets 9,032    1,252 
 
Total assets less current liabilities 9,032    1,642 
Creditors: amount falling due after more than one year 5 (2,750)   (796)
Net assets 6,282    846 
 

Capital and reserves
     
Called up share capital 6 1    1 
Profit and loss account 6,281    845 
Shareholders' funds 6,282    846 
 


For the year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 28 July 2025 and were signed by:


-------------------------------
Mohsin Patel
Director
1
General Information
YOUR EYE CARE LTD is a private company, limited by shares, registered in England and Wales, registration number 12286983, registration address 10 Cameron Road, Ground Floor Front , Ilford, IG3 8LA.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 5 Straight Line
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 November 2023 1,950    1,950 
Additions  
Disposals  
At 31 October 2024 1,950    1,950 
Depreciation
At 01 November 2023 1,560    1,560 
Charge for year 390    390 
On disposals  
At 31 October 2024 1,950    1,950 
Net book values
Closing balance as at 31 October 2024  
Opening balance as at 01 November 2023 390    390 


4.

Creditors: amount falling due within one year

2024
£
  2023
£
Trade Creditors 6,000    10,000 
Corporation Tax 1,367    95 
Accrued Expenses 540   
7,907    10,095 

5.

Creditors: amount falling due after more than one year

2024
£
  2023
£
Directors' Loan Accounts 2,750    796 
2,750    796 

6.

Share Capital

Authorised
1 Class A share of £1.00 each
Allotted, called up and fully paid
2024
£
  2023
£
1 Class A share of £1.00 each  
 

2